Intranasal Delivery of circATF7IP siRNA via Lipid Nanoparticles Alleviates LPS‐induced Depressive‐Like Behaviors
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202402219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Minzi Ju und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing, Jiangsu, …. Hauptthemen laut MEDLINE: Administration, Intranasal, RNA, Small Interfering, RNA, Circular, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: The Start-up Research Fund of Southeast University, The Fundamental Research Funds for the Central Universities, The Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Major depressive disorder (MDD) is a prevalent mental disorder that significantly impacts social and psychological function, but no effective medication is currently available. Circular RNAs (circRNAs) have been reported to participate in the pathogenesis of MDD which are envisioned as promising therapeutic targets. However, nonviral‐based delivery strategies targeting circRNA against MDD are not thoroughly investigated. Here, it is identified that circATF7IP is significantly upregulated in plasma samples and positively correlated with 24‐Hamilton Depression Scale (HAMD‐24) scores of MDD patients. Synergistic amine lipid nanoparticles (SALNPs) are designed to deliver siRNA targeting circATF7IP (si‐circATF7IP) into the hippocampus brain region by intranasal administration. Intranasal delivery of SALNP‐si‐circATF7IP successfully alleviated the depressive‐like behaviors in the LPS‐induced mouse depression model via decreasing CD11b + CD45 dim microglia population and pro‐inflammatory cytokine productions (TNF‐α and IL‐6). These results indicate that the level of circATF7IP positively correlates with MDD pathogenesis, and SALNP delivery of si‐circATF7IP via intranasal administration is an effective strategy to ameliorate LPS‐induced depressive‐like behaviors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, China.
- Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, China.
- Institute of Psychosomatics, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, China.
- Department of Psychiatry, the Third People's Hospital of Huai'an, Huai'an, Jiangsu, 223001, China.
- Co-innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu, 226019, China.
- Institute of Life Sciences, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, Jiangsu, 210009, China.
ORCID-Profile: Honghong Yao
Förderung
- The Start-up Research Fund of Southeast University
- The Fundamental Research Funds for the Central Universities
- The Natural Science Foundation of Jiangsu Province
- The National Natural Science Foundation of China
- The National Natural Science Foundation of Distinguished Young Scholars
- The Science and Technology innovation 2030-Major Project of the Ministry of Science and Technology of China
Zitieren
APA
Ju, M., Zhang, Z., Gao, F., Chen, G., Zhao, S., Wang, D., Wang, H., Jia, Y., Shen, L., Yuan, Y., & Yao, H. (2024). Intranasal Delivery of circATF7IP siRNA via Lipid Nanoparticles Alleviates LPS‐induced Depressive‐Like Behaviors. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402219
Vancouver
Ju M, Zhang Z, Gao F, Chen G, Zhao S, Wang D, et al. Intranasal Delivery of circATF7IP siRNA via Lipid Nanoparticles Alleviates LPS‐induced Depressive‐Like Behaviors. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402219
BibTeX
@article{Ju2024,
author = {Ju, Minzi and Zhang, Zhongkun and Gao, Feng and Chen, Gang and Zhao, Sibo and Wang, Dan and Wang, Huijuan and Jia, Yanpeng and Shen, Ling and Yuan, Yonggui and Yao, Honghong},
title = {Intranasal Delivery of circATF7IP siRNA via Lipid Nanoparticles Alleviates LPS‐induced Depressive‐Like Behaviors},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202402219}
}
EUVIMED